bio rad cat mca711g (Bio-Rad)
96
Structured Review
Bio-Rad
bio rad cat mca711g
Bio Rad Cat Mca711g, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 96/100, based on 1155 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bio+rad+cat+mca711g/Rat+anti+Mouse+CD11b/pmc12817821-141-49-49
Average 96 stars, based on 1155 article reviews
Bio Rad Cat Mca711g, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 96/100, based on 1155 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bio+rad+cat+mca711g/Rat+anti+Mouse+CD11b/pmc12817821-141-49-49
Average 96 stars, based on 1155 article reviews
bio rad cat mca711g - by Bioz Stars,
2026-09
96/100 stars
Images
Related Articles
Blocking Assay:Article Title: A novel vector design targeting the blood-brain barrier with the brain-specific AAV-BR1 vector enables abluminal protein secretion from brain endothelial cells in vitro. Article Snippet: 358 359 Immunocytochemistry 360 Primary mBECs and mixed glial cells were incubated with blocking buffer containing 361 5 % milk, 0.3 % Triton-X100 (Merck KGaA, cat# X100), and diluted in PBS for 1 hour 362 at RT. .. Next, primary antibodies diluted in blocking buffer were added and incubated 363 at 4°C overnight with gentle rocking. mBECs were labeled with rabbit anti-Avitag AR TIC LE IN PR ES S 364 1:300 (Genscript, cat# A00674) and mouse anti-ZO-1 1:200 (Invitrogen, cat# 339100), 365 while mixed glial cells were labeled with rabbit anti-Avitag 1:300 and rat anti-CD11b 366 1:200 ( Article Title: A novel vector design targeting the blood-brain barrier with the brain-specific AAV-BR1 vector enables abluminal protein secretion from brain endothelial cells in vitro Article Snippet: .. Subsequently, the brain slices were incubated with the primary antibodies rabbit anti-mCherry (1:500, Rockland, cat# 600-401-P16), in combination with either rat anti-cluster of differentiation 11b (CD11b) (1:200, Article Title: A novel vector design targeting the blood-brain barrier with the brain-specific AAV-BR1 vector enables abluminal protein secretion from brain endothelial cells in vitro Article Snippet: Primary mBECs and mixed glial cells were incubated with blocking buffer containing 5% milk, 0.3% Triton-X100 (Merck KGaA, cat# X100), and diluted in PBS for 1 h at RT. .. Next, primary antibodies diluted in blocking buffer were added and incubated at 4 °C overnight with gentle rocking. mBECs were labeled with rabbit anti-Avitag 1:300 (Genscript, cat# A00674) and mouse anti-ZO-1 1:200 (Invitrogen, cat# 339100), while mixed glial cells were labeled with rabbit anti-Avitag 1:300 and rat anti-CD11b 1:200 ( Incubation:Article Title: A novel vector design targeting the blood-brain barrier with the brain-specific AAV-BR1 vector enables abluminal protein secretion from brain endothelial cells in vitro. Article Snippet: 358 359 Immunocytochemistry 360 Primary mBECs and mixed glial cells were incubated with blocking buffer containing 361 5 % milk, 0.3 % Triton-X100 (Merck KGaA, cat# X100), and diluted in PBS for 1 hour 362 at RT. .. Next, primary antibodies diluted in blocking buffer were added and incubated 363 at 4°C overnight with gentle rocking. mBECs were labeled with rabbit anti-Avitag AR TIC LE IN PR ES S 364 1:300 (Genscript, cat# A00674) and mouse anti-ZO-1 1:200 (Invitrogen, cat# 339100), 365 while mixed glial cells were labeled with rabbit anti-Avitag 1:300 and rat anti-CD11b 366 1:200 ( Article Title: A novel vector design targeting the blood-brain barrier with the brain-specific AAV-BR1 vector enables abluminal protein secretion from brain endothelial cells in vitro Article Snippet: .. Subsequently, the brain slices were incubated with the primary antibodies rabbit anti-mCherry (1:500, Rockland, cat# 600-401-P16), in combination with either rat anti-cluster of differentiation 11b (CD11b) (1:200, Article Title: A novel vector design targeting the blood-brain barrier with the brain-specific AAV-BR1 vector enables abluminal protein secretion from brain endothelial cells in vitro Article Snippet: Primary mBECs and mixed glial cells were incubated with blocking buffer containing 5% milk, 0.3% Triton-X100 (Merck KGaA, cat# X100), and diluted in PBS for 1 h at RT. .. Next, primary antibodies diluted in blocking buffer were added and incubated at 4 °C overnight with gentle rocking. mBECs were labeled with rabbit anti-Avitag 1:300 (Genscript, cat# A00674) and mouse anti-ZO-1 1:200 (Invitrogen, cat# 339100), while mixed glial cells were labeled with rabbit anti-Avitag 1:300 and rat anti-CD11b 1:200 ( Gentle:Article Title: A novel vector design targeting the blood-brain barrier with the brain-specific AAV-BR1 vector enables abluminal protein secretion from brain endothelial cells in vitro. Article Snippet: 358 359 Immunocytochemistry 360 Primary mBECs and mixed glial cells were incubated with blocking buffer containing 361 5 % milk, 0.3 % Triton-X100 (Merck KGaA, cat# X100), and diluted in PBS for 1 hour 362 at RT. .. Next, primary antibodies diluted in blocking buffer were added and incubated 363 at 4°C overnight with gentle rocking. mBECs were labeled with rabbit anti-Avitag AR TIC LE IN PR ES S 364 1:300 (Genscript, cat# A00674) and mouse anti-ZO-1 1:200 (Invitrogen, cat# 339100), 365 while mixed glial cells were labeled with rabbit anti-Avitag 1:300 and rat anti-CD11b 366 1:200 ( Article Title: A novel vector design targeting the blood-brain barrier with the brain-specific AAV-BR1 vector enables abluminal protein secretion from brain endothelial cells in vitro Article Snippet: .. Subsequently, the brain slices were incubated with the primary antibodies rabbit anti-mCherry (1:500, Rockland, cat# 600-401-P16), in combination with either rat anti-cluster of differentiation 11b (CD11b) (1:200, Article Title: A novel vector design targeting the blood-brain barrier with the brain-specific AAV-BR1 vector enables abluminal protein secretion from brain endothelial cells in vitro Article Snippet: Primary mBECs and mixed glial cells were incubated with blocking buffer containing 5% milk, 0.3% Triton-X100 (Merck KGaA, cat# X100), and diluted in PBS for 1 h at RT. .. Next, primary antibodies diluted in blocking buffer were added and incubated at 4 °C overnight with gentle rocking. mBECs were labeled with rabbit anti-Avitag 1:300 (Genscript, cat# A00674) and mouse anti-ZO-1 1:200 (Invitrogen, cat# 339100), while mixed glial cells were labeled with rabbit anti-Avitag 1:300 and rat anti-CD11b 1:200 ( Labeling:Article Title: A novel vector design targeting the blood-brain barrier with the brain-specific AAV-BR1 vector enables abluminal protein secretion from brain endothelial cells in vitro. Article Snippet: 358 359 Immunocytochemistry 360 Primary mBECs and mixed glial cells were incubated with blocking buffer containing 361 5 % milk, 0.3 % Triton-X100 (Merck KGaA, cat# X100), and diluted in PBS for 1 hour 362 at RT. .. Next, primary antibodies diluted in blocking buffer were added and incubated 363 at 4°C overnight with gentle rocking. mBECs were labeled with rabbit anti-Avitag AR TIC LE IN PR ES S 364 1:300 (Genscript, cat# A00674) and mouse anti-ZO-1 1:200 (Invitrogen, cat# 339100), 365 while mixed glial cells were labeled with rabbit anti-Avitag 1:300 and rat anti-CD11b 366 1:200 ( Article Title: A novel vector design targeting the blood-brain barrier with the brain-specific AAV-BR1 vector enables abluminal protein secretion from brain endothelial cells in vitro Article Snippet: Primary mBECs and mixed glial cells were incubated with blocking buffer containing 5% milk, 0.3% Triton-X100 (Merck KGaA, cat# X100), and diluted in PBS for 1 h at RT. .. Next, primary antibodies diluted in blocking buffer were added and incubated at 4 °C overnight with gentle rocking. mBECs were labeled with rabbit anti-Avitag 1:300 (Genscript, cat# A00674) and mouse anti-ZO-1 1:200 (Invitrogen, cat# 339100), while mixed glial cells were labeled with rabbit anti-Avitag 1:300 and rat anti-CD11b 1:200 ( |